Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation
JM Velázquez-Enríquez, JC Santos-Álvarez… - Biochemical and …, 2024 - Elsevier
Aims Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition, the
cause of which remains unknown and for which no effective therapeutic treatment is …
cause of which remains unknown and for which no effective therapeutic treatment is …
Integrated whole‐exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with …
D Zhou, Y Li, Q Liu, X Deng, L Chen, M Li… - Cancer …, 2024 - Wiley Online Library
Objective The genomic and molecular ecology involved in the stepwise continuum
progression of lung adenocarcinoma (LUAD) from adenocarcinoma in situ (AIS) to minimally …
progression of lung adenocarcinoma (LUAD) from adenocarcinoma in situ (AIS) to minimally …
Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis
S Dasgupta - Gene Reports, 2024 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is characterized by progressive fibrosis in
the lung parenchyma. Given the fact that IPF patients are at significant risk of developing …
the lung parenchyma. Given the fact that IPF patients are at significant risk of developing …